Implementing clinical trials on an international platform: Challenges and perspectives

Journal of the Neurological Sciences

Volumn 313, Issue 1-2, 2012, Pages 1-6

  Minisman, Greg ^a   Bhanushali, Minal ^b   Conwit, Robin ^b   Wolfe, Gil I ^c   Aban, Inmaculada ^a   Kaminski, Henry J ^d   Cutter, Gary ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Clinical research; International clinical trials; Multinational clinical trials; Myasthenia gravis; Phase 3 clinical trials; Thymectomy

Indexed keywords

PREDNISONE;

CERTIFICATION; CLINICAL PROTOCOL; CONTRACT; DATA ANALYSIS; FINANCIAL MANAGEMENT; GOVERNMENT REGULATION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; MONITORING; MULTICENTER STUDY (TOPIC); MYASTHENIA GRAVIS; PATIENT SAFETY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; RESEARCH ETHICS; RESEARCH SUBJECT; REVIEW; STAFF TRAINING; SURGEON; THYMECTOMY;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; HUMANS; INTERNATIONALITY; WORLD HEALTH;

EID: 84855586108     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.10.004     Document Type: Review

References (10)

1. I.B. Aban, G.I. Wolfe, G. Cutter, H. Kaminski, A. Jaretzki III, and G. Minisman The MGTX experience: challenges in planning and executing an international, multicenter clinical trial J Neuroimmunol 217 1-2 2009 103 (Erratum: Journal of Neuroimmunol. 201-202(2008)80-84)
2. J. Neaton, A. Babiker, M. Bohnhorst, J. Darbyshire, E. Denning, and A. Frishman Regulatory impediments jeopardizing the conduct of clinical trials in Europe funded by National Institute of Health Clin Trials 7 2010 705 718
3. T. Bollyky, I. Cockburn, and E. Berndt Bridging the gap: improving clinical development and the regulatory pathways for health products for neglected diseases Clin Trials 7 2010 719 734
4. S. Yusuf Damage to important clinical trials by over-regulation Clin Trials 7 2010 622 625
5. Bilbault P, Belorgey C, Zannad F, Golinelli D, Pletan Y, participants of Round Table n°4 of Giens XXV. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011. Therapie 2010; Jul-Aug; 65(4):301-8, 291-9.
6. C. Kubiak, F. de Andres-Trelles, W. Kuchinke, K.H. Huemer, S. Thirstrup, and K. Whitfield Common definition for categories of clinical research: a prerequisite for a survey on regulatory requirements by the European Clinical Research Infrastructures Network (ECRIN) Trials 10 2009 95 Oct 16
7. N. Marina, S. Bielack, J. Whelan, S. Smeland, M. Krailo, and M.R. Sydes International collaboration is feasible in trials for rare conditions: the EURAMOS experience Cancer Treat Res 152 2009 339 353
8. Gareth Griffiths, Scientific Director, and Wales Cancer Trials Unit Expediting protocol review and activation Workshop on Overcoming Barriers to International Collaboration in Rare Cancer Clinical Trials Dec. 2010 National Cancer Institute Rockville, MD https://wiki.nci.nih.gov/display/ICWG/ Overcoming+Barriers+to+International+Collaboration+in+Rare+Cancer+Clinical+Tr ials
9. L. Mauri, D.J. Kereiakes, S.L. Normand, S.D. Wiviott, D.J. Cohen, and D.R. Holmes Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either a drug eluting stent or bare metal stent placement for the treatment of coronary artery lesions Am Heart J 160 6 Dec. 2010 1035 1041 1041.e1
10. H.P. Adams Jr., M.B. Effron, J. Torner, A. Davalos, J. Frayne, and P. Teal Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency treatment of Stroke Trial (AbESTT-II) Stroke 39 1 Jan. 2008 87 99 Epub 2007 Nov 21